CAPTRUST Financial Advisors
XERS icon

CAPTRUST Financial Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

CAPTRUST Financial Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.9K Buy
14,815
+2,999
+25% +$19.9K ﹤0.01% 2830
2025
Q4 		$92.8K Sell
11,816
-88
-0.7% -$693 ﹤0.01% 2620
2025
Q3 		$96.9K Buy
11,904
+1,098
+10% +$7.29K ﹤0.01% 2516
2025
Q2 		$50.5K Sell
10,806
-976
-8% -$4.47K ﹤0.01% 2423
2025
Q1 		$64.7K Buy
+11,782
New +$47.6K ﹤0.01% 2269
2021
Q4 		– Sell
-2,783
Closed -$7K – 4940
2021
Q3 		$7K Sell
2,783
-216
-7% -$627 ﹤0.01% 3824
2021
Q2 		$12K Sell
2,999
-106
-3% -$405 ﹤0.01% 3458
2021
Q1 		$14K Buy
+3,105
New +$16.7K ﹤0.01% 3245

Other funds holding XERS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return